Antenatal steroid treatment and adverse fetal effects: What is the evidence?

Journal of the Society for Gynecologic Investigation

Volumn 7, Issue 5, 2000, Pages 269-278

  Kay, Helen H ^a   Bird, Ian M ^a   Coe, Christopher L ^b   Dudley, Donald J ^c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Adverse fetal effects; Antenatal steroid treatment

Indexed keywords

BETAMETHASONE; DEXAMETHASONE; GLUCOCORTICOID; STEROID;

BRAIN DEVELOPMENT; BRAIN SIZE; CLINICAL TRIAL; DOSE TIME EFFECT RELATION; DRUG REEXPOSURE; FETUS; FETUS DEVELOPMENT; FETUS LUNG MATURATION; FETUS OUTCOME; HUMAN; LOW BIRTH WEIGHT; NERVE CELL DIFFERENTIATION; NONHUMAN; PREGNANCY; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; REVIEW; SPECIES DIFFERENCE; STANDARDIZATION; STEROID THERAPY;

ADRENAL CORTEX HORMONES; ANIMAL; BIRTH WEIGHT; COGNITION; FEMALE; FETAL ORGAN MATURITY; HUMAN; IMMUNITY; INFANT, NEWBORN; LABOR, PREMATURE; LUNG; PREGNANCY; RESPIRATORY DISTRESS SYNDROME; RISK FACTORS;

EID: 0033780165     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-5576(00)00075-7     Document Type: Review

References (79)

1. Liggins G.C., Howie R.N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 50:1972;515-525.
2. Liggins G.C. Premature delivery of foetal lambs infused with glucocorticoids. J Endocrinol. 45:1969;515-523.
3. DeLemos RA, Shermeta DW, Knelson JH, Kotas R, Avery ME. Acceleration of appearance of pulmonary surfactant in the fetal lamb by administration of corticosteroids. Am Rev Respir Dis 1970;102:459.
4. Kotas RV, Avery ME. Accelerated appearance of pulmonary surfactant in the fetal rabbit. J Appl Physiol 1971;30:358.
5. Naeye RL, Harcke HT, Blanc WA. Adrenal gland structure and the development of hyaline membrane disease. Pediatrics 1971;47:650.
6. Ballard R.A., Ballard P.L., Creasy R.K., et al. Respiratory disease in very-low-birth weight infants after prenatal thyrotropin-releasing hormone and glucocorticoid. Lancet. 339:1992;510-515.
7. Fujiwara T., Maeta H., Chida S., et al. Artificial surfactant therapy in hyaline membrane disease. Lancet. i:1980;55-59.
8. Wellmann K.F., Volk B.W. Fine structural changes in the rabbit placenta induced by cortisone. Arch Pathol. 94:1972;147-157.
9. Pratt L., Magness R.R., Phernetton T., Hendricks S.K., Abbott D.H., Bird I.M. Repeated use of betamethasone in rabbits Effects of treatment variation on adrenal suppression, pulmonary maturation, and pregnancy outcome . Am J Obstet Gynecol. 180:1999;1-11.
10. Frank L., Roberts R.J. Effects of low-dose prenatal corticosteroid administration on the premature rate. Biol Neonate. 36:1979;1-9.
11. DeSouza S.W., Adlard B.P.F. Growth of sucking rats after treatment with dexamethasone or cortisol Implications for steroid treatment in human infants . Arch Dis Child. 48:1973;519-522.
12. Barrada M.I., Blomquist C.H., Kolts C. The effects of betamethasone on fetal development in the rabbit. Am J Obstet Gynecol. 136:1980;234-238.
13. Sun B., Jobe A.H., Ridger E., Ikegami M. Single dose versus two doses of betamethasone for lung maturation in preterm rabbits. Pediatr Res. 33:1993;256-260.
14. Conley A.J., Bird I.M. The role of cytochrome P450 17α-hydroxylase and 3β-hydroxysteroid dehydrogenase in the integration of adrenal and gonadal steroidogenesis via the Δ5 and Δ4 pathways. Biol. Reprod. 56:1997;789-799.
15. Fowden A.L., Szemere J., Hughes P., Gilmour R.S., Forhead A.J. The effects of cortisol on the growth rate of the sheep fetus during late gestation. J Endocrinol. 151:1996;97-105.
16. Ikegami M., Jobe A.H., Newnham J., Polk D.H., Willet K.E., Sly P. Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs. Am J Respir Crit Care Med. 156:1997;178-184.
17. Barker D.J. Fetal origins of cardiovascular disease. Ann Med. 31:(Suppl 1):1999;3-6.
18. Quinlivan J.A., Archer M.A., Dunlop S.A., Evans S.F., Beazley L.D., Newnham J.P. Fetal growth retardation, particularly within lymphoid organs, following repeated maternal injections of betamethasone in sheep. J Obstet Gynaecol Res. 24:1998;173-182.
19. Huang W.L., Beazley L.D., Quinlivan J.A., Evans S.F., Newnham J.P., Dunlop S.A. Effect of corticosteroids on brain growth in fetal sheep. Obstet Gynecol. 94:1999;213-218.
20. Dodic M., May C.N., Wintour E.M., Coghlan J.P. An early prenatal exposure to excess glucocorticoid leads to hypertensive offspring in sheep. Clin Sci. 94:1998;149-155.
21. Dunlop S.A., Archer M.A., Quinlivan J.A., Beazley L.D., Newnham J.P. Repeated prenatal corticosteroids delay myelination in the ovine central nervous system. J Matern Fetal Med. 6:1997;309-313.
22. Uno H., Eisele S., Sakai A., et al. Neurotoxicity of glucocorticoids in the primate brain. Horm Behav. 28:1994;236-248.
23. Jobe A.H., Polk D., Ikegami M., et al. Lung responses to ultrasound-guided fetal treatment with corticosteroids in preterm lambs. J Appl Physiol. 75:1993;2099-2105.
24. France J.T., Magness R.R., Murry B.A., Rosenfeld C.R., Mason J.I. The regulation of ovine placental steroid 17α-hydroxylase and aromatase by glucocorticoid. Mol Endocrinol. 2:1988;193-199.
25. Mason J.I., France J.T., Magness R.R., Murry B.A., Rosenfeld C.R. Ovine placental steroid 17α-hydroxylase/C-17,20-lyase, aromatase and sulphatase in dexamethasone-induced and natural parturition. J Endocrinol. 122:1989;351-359.
26. Newnham J.P., Evans S.F., Godfrey M.E., Huang W.L., Ikegami M., Jobe A. Maternal, but not fetal, administration of corticosteroids restricts fetal growth. J Matern Fetal Med. 8:1999;81-87.
27. Jobe A.H., Wada N., Berry L.M., Ikegami M., Ervin M.G. Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep. Am J Obstet Gynecol. 178:1998;880-885.
28. Jobe A.H., Polk D.H., Ervin M.G., Padbury J.F., Rebello C.M., Ikegami M. Preterm betamethasone treatment of fetal sheep Outcome after term delivery . J Soc Gynecol Invest. 3:1996;250-258.
29. Sumi S.M., Truog W.E., Kessler D.M. Maternal corticosteroid therapy and the fetal brain in experimental hyaline membrane disease. Pediatr Res. 15:1984;440-445.
30. Castracane V.D. The effect of dexamethasone administration at different stages of gestation on maternal plasma steroid concentrations in the baboon (Papio cynocephalus). Hum Reprod. 13:1998;2282-2285.
31. Kessler D.L., Truog W.E., Murphy J.H., et al. Experimental hyaline membrane disease in the premature monkey Effects of antenatal dexamethasone . Am Rev Respir Dis. 126:1982;62-69.
32. Dayer A.M., Kapanci Y., Rademakers Rusy L.M., De Mey J., Will J.A. Increased numbers of neuroepithelial bodies (NEB) in lungs of fetal rhesus monkeys following maternal dexamethasone treatment. Cell Tissue Res. 239:1985;703-705.
33. Johnson J.W., Mitzner W., London W.T., et al. Long-term effects of betamethasone on fetal development. Am J Obstet Gynecol. 141:1981;1053-1064.
34. Engle M.J., Kemnitz J.W., Yao T.J., Perelman R.H., Farell P.M. Effects of maternal dexamethasone therapy on fetal lung development in the rhesus monkey. Am J Perinatol. 13:1996;399-407.
35. Novy M.J., Walsh S.W. Dexamethasone and estradiol treatment in pregnant rhesus macaques Effects on gestational length, maternal plasma hormones, and fetal growth . Am J Obstet Gynecol. 145:1983;920-931.
36. Coe C.L., Kemnitz J.W., Schneider M.L. Vulnerability of placental antibody transfer and fetal complement synthesis to disturbance of the pregnant monkey. J Med Primatol. 22:1993;294-300.
37. Coe C.L., Lubach G.R., Karaszewski J. Effects of prenatal stress on recognition of self and nonself in the primate neonate. Biol Neonate. 76:1999;301-310.
38. Epstein M.F., Farrell P.M., Sparks M.W., Pepe G., Driscoll S.G., Chez R.A. Maternal betamethasone and fetal growth and development in the monkey. Am J Obstet Gynecol. 127:1977;261-263.
39. Johnson J.W., Mitzner W., London W.T., Palmer A.E., Scott R. Betamethasone and the rhesus fetus Multisystemic effects . Am J Obstet Gynecol. 133:1979;677-684.
40. Leakey J.E.A., Althaus Z.R., Bailey J.R., Slikker W. Dexamethasone induces hepatic cytochrome P-450 content and increases certain monooxygenase activities in rhesus monkey fetuses. Biochem Pharmacol. 35:1986;1389-1391.
41. Uno H., Lohmiller L., Thieme C., et al. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus. Dev Brain Res. 53:1990;157-167.
42. Walsh S.W., Norman R.L., Novy M.J. In utero regulation of rhesus monkey fetal adrenal Effects of dexamethasone, adrenocorticotrophin, thyrotropin-releasing hormone, prolactin, human chorionic gonadotropin, and alpha-melanocyte-stimulating hormone on fetal and maternal plasma steroids . Endocrinology. 104:1979;1805-1813.
43. Challis J.R.G., Davies I.J., Bernirschke K., et al. The effects of dexamethasone on the peripheral plasma concentration of androstenedione, testosterone, and cortisol in the pregnant rhesus monkey. Endocrinology. 96:1975;185-192.
44. Ducsay C.A., Ervin G., Kaushi K.M., Matsumoto T. Myometrial contractile responsiveness to oxytocin after dexamethasone suppression of circadian uterine activity in pregnant rhesus macaques during late gestation. Am J Obstet Gynecol. 167:1992;1636-1641.
45. Althaus Z.R., Bailey J.R., Leakey J.E.A., Slikker W. Transplacental metabolism of dexamethasone and cortisol in the late gestational age rhesus monkey (Macaca mulatta). Dev Pharmacol Ther. 9:1986;332-349.
46. Sawyer R., Hendricks A., Osburn B., Terrel T. Abnormal morphology of the fetal monkey (Macaca mulatta) thymus exposed to a corticosteroid. J Med Primatol. 6:1977;145-150.
47. Coe CL, Lubach GR. Prenatal influences on neuroimmune set points in infancy. Annal N Y Acad Sci. In press.
48. Gamsu H.R., Mullinger B.M., Donnai P., Dash C.H. Antenatal administration of betamethasone to prevent respiratory distress syndrome in preterm infants Report of a UK multicentre trial . Br J Obstet Gynaecol. 96:1989;401-410.
49. Yunis K.A., Bitar F.F., Hayek P., Mroueh S.M., Mikati M. Transient hypertrophic cardiomyopathy in the newborn following multiple doses of antenatal corticosteroids. Am J Perinatol. 16:1999;17-21.
50. French N.P., Hagan R., Evans S.F., Godfrey M., Newnham J.P. Repeated antenatal corticosteroids Size at birth and subsequent development . Am J Obstet Gynecol. 180:1999;114-121.
51. Gennser G., Rymark P., Isberg P.E. Low birth weight and risk of high blood pressure in adulthood. BMJ. 296:1988;1498-1500.
52. Effect of antenatal steroid administration on the infant Longterm follow-up . J Pediatr. 104:1984;259-267.
53. Howie R.N. Pharmacological acceleration of lung maturation. Villee C.A., Villee D.B., Zuckerman J. Respiratory distress syndrome. 1973;385-396 Academic Press, London.
54. de Haas H., Neuvel J., Schmand B., Treffers P.E., Koppe J.G., Hoeks J. Physical development and medical history of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome A 10- to 12-year follow-up . Pediatrics. 86:1990;65-70.
55. Banks B.A., Cnaan A., Morgan M.A., et al. Multiple courses of antenatal corticosteroids and outcome of premature neonates. Am J Obstet Gynecol. 181:1999;709-717.
56. Salokorpi T., Sajaniemi N., Hallback H., et al. Randomized study of the effect of antenatal dexamethasone on growth and development of premature children at the corrected age of 2 years. Acta Paediatr. 86:1997;294-298.
57. Howie R.N., Liggins G.C. The New Zealand study of antepartum glucocorticoid treatment. Farrel P.M. Lung development Biological and clinical perspectives. II . 1982;255-265 Academic Press, New York.
58. Papile L.A., Stoll B., Donovan E., et al. A multi-center trial of two dexamethasone regimens in ventilator-dependent premature infants. N Engl J Med. 338:1998;1112-1118.
59. O'Shea T.M., Kothadia J.M., Klinepeter K.L., et al. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birthweight infants Outcome of study participants at 1-year adjusted age . Pediatrics. 104:1999;15-21.
60. Yeh TF, Lin YJ, Huang CC, et al. Early dexamethasone therapy in preterm infants: A follow-up study. Pediatrics 1998;101:E7.
61. Esplin MS, Fausett MB, Smith S, et al. Multiple courses of antenatal steroids are associated with a delay in long-term psychomotor development in children with birth weight < 1,500 grams. Am J Obstet Gynecol 2000;182:A27.
62. Bradley B.S., Kumar S.P., Mehta P.N., Ezhathachau S.G. Neonatal cushingoid syndrome resulting from serial courses of antenatal betamethasone. Obstet Gynecol. 83:1994;869-872.
63. Abassi S, Hirsch D, Davis J, et al. Effect of single vs. multiple courses of antenatal steroids on neonatal outcome. Am J Obstet Gynecol 1997;179:A138.
64. Vermillion S, Soper D, Newman R. Neonatal sepsis and death after multiple doses of antenatal betamethasone. Am J Obstet Gynecol 2000;182:A28.
65. Ghidini A., Salafia C.M., Minior V.K. Repeated courses of steroids in preterm membrane rupture do not increase the risk of histologic chorioamnionitis. Am J Perinatol. 14:1997;309-313.
66. Wright L.L., Horbar J.D., Gunkel H., et al. Evidence from multicenter networks on the current use and effectiveness of antenatal corticosteroids in low birthweight infants. Am J Obstet Gynecol. 173:1995;263-269.
67. Wright L.L., Verter J., Younes N., et al. Antenatal corticosteroid administration and neonatal outcome in very low birth weight infants The NICHD Neonatal Research Network . Am J Obstet Gynecol. 173:1995;269-274.
68. Antenatal corticosteroid treatment and neonatal outcomes for infants 501 to 1500 gm in the Vermont-Oxford Trials Network. Am J Obstet Gynecol. 173:1995;275-281.
69. Crowley P.A. Antenatal corticosteroid therapy A meta-analysis of the randomized trials, 1972 to 1994 . Am J Obstet Gynecol. 173:1995;322-335.
70. Allen VM, Allen AC, Usher RA, Liston RM. The effect of multiple courses of maternal antenatal steroids on the prevention of complications of prematurity. Am J Obstet Gynecol 1997;176:A136.
71. Debbs R, Abbasi S, Tolosa J, Weiner S, Wapner R. Does serial versus single course betamethasone therapy increase neonatal morbidity? Am J Obstet Gynecol 1997;179:A130.
72. Cunningham D.S., Evans E.E. The effects of betamethasone on maternal cellular resistance to infection. Am J Obstet Gynecol. 165:1991;610-615.
73. Elimian A., Verma U., Visintainer P., Tejani N. Effectiveness of multidose antenatal steroids. Obstet Gynecol. 95:2000;34-36.
74. Vermillion S.T., Soper D.E., Chasedunn-Roark J. Neonatal sepsis after betamethasone administration to patients with preterm premature rupture of membranes. Am J Obstet Gynecol. 181:1999;320-327.
75. Caudle M.R., Harbert G.M., Singhas C.A. Effect of betamethasone on fetal macrophage function Depression of adherence of immunoglobulin-coated red blood cells . Am J Reprod Immunol. 1:1981;182-184.
76. Fuenfer M.M., Herson V.C., Raye J.R., et al. The effect of betamethasone on neonatal neutrophil chemotaxis. Pediatr Res. 22:1987;150-153.
77. Shea C., Morse E.D. Inhibition of human neutrophil chemotaxis by corticosteroids. Ann Clin Lab Sci. 8:1978;30-33.
78. Eisenfeld L., Rosenkrantz T.S., Block C., et al. Effects of corticosteroids on the maturation of neutrophil motility in very low birthweight neonates. Am J Perinatol. 11:1994;163-166.
79. Barak M., Cohen A., Herschkowitz S. Total leukocyte and neutrophil count changes associated with antenatal betamethasone administration in premature infants. Acta Paediatr. 81:1992;760-763.